Overview

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to assess which antidepressants work the best in older adults who have treatment-resistant depression (TRD).
Phase:
Phase 4
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
National Institute of Mental Health (NIMH)
Patient-Centered Outcomes Research Institute
Treatments:
Antidepressive Agents
Aripiprazole
Bupropion
Lithium Carbonate
Nortriptyline